MEDI3506
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for MEDI3506, covering 2023-09-28 to 2025-02-27. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis [Phase 2]